U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - November 8, 2007
The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were more HIV infections
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Monday, October 22, 2007
WHAT: Viral load-the amount of virus in the blood of an HIV-infected person-has long been viewed as the chief indicator of how quickly someone infected with HIV infection progresses to AIDS. New data published in Nature Immunology builds on previous work that suggests that several other factors in addition to viral loa
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, October 10, 2007
CONTACT: NIAID News Office, 301-402-1663,
October 15, 2007, marks the fifth annual National Latino AIDS Awareness Day. On this day, the National Institute of Allergy and Infectious Diseases (NIAID) pledges to continue working toward reducing the burden of HIV/AIDS in the Latino community in the United States . We commemorate everyone who has been lost to the d
National Institute of Allergy and Infectious Diseases; National Institutes of Health - Wednesday, July 25, 2007
Media Contact: Jason Socrates Bardi, (301) 402-1663, jbardi@niaid.nih.gov
South African Clinical Trial Modified Because of Initial Data Hundreds of thousands of babies around the world are born each year with HIV--more than half a million in 2006 alone. Caring for these children is complicated by the fact that their immune systems are not fully developed in the first year of life, which make
National Institute of Allergy and Infectious Diseases; National Institutes of Health - Thursday, July 19, 2007
Media Contact: Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection. The clearer picture of host responses to
National Institute of Allergy and Infectious Diseases; National Institutes of Health - Wednesday, May 16, 2007
Media Contact: Kathy Stover, (301) 402-1663, kstover@niaid.nih.gov
A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Rather, the first successf
U.S. Department of Health and Human Services; National Institutes of Health; NIH News National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, May 16, 2007
On, National Asian and Pacific Islander HIV/AIDS Awareness Day, we honor those who have dedicated themselves to promoting HIV/AIDS awareness and education among people of Asian and Pacific Island heritage. It is also a day to remember those whom we have lost to HIV/AIDS and to recommit ourselves to stopping this deadly
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Monday, May 14, 2007
May 18, 2007 marks the 10th annual HIV Vaccine Awareness Day, an opportunity to reflect upon the more than two decades of progress worldwide in the search for a safe and effective HIV vaccine. Today, many challenges remain, but we look forward with optimism as the HIV vaccine candidates in clinical trials today are amo
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, May 8, 2007
U.S. and Indian health officials have renewed the Indo-U.S. Vaccine Action Program (VAP), a 20-year-old bilateral collaboration supporting research on vaccines, immunology and related biomedical issues. The VAP aims to reduce the burden of vaccine-preventable diseases of public health significance in India, the
National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 23, 2007
On March 24, 1882, Dr. Robert Koch announced the discovery of Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis (TB). Dr. Koch s remarkable scientific achievement was the first step toward developing tools to control the disease. We at the National Institutes of Health (NIH) acknowledge the accom
National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 14, 2007
The National Institute of Allergy and Infectious Diseases (NIAID) today announced the appointment of five new members to the National Advisory Allergy and Infectious Diseases Council, its principal advisory body. NIAID is part of National Institutes of Health (NIH), an agency within the Department of Health and Human S
National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 12, 2007
Media Contact: Kathy Stover, kstover@niaid.nih.gov
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced 60 U.S. and international institutions selected as HIV/AIDS Clinical Trials Units (CTUs) in a newly restructured system of six HIV/AIDS clinical research networks. NIAID expects to fund ad
National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 10, 2007
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health The commemoration of the second annual National Women and Girls HIV/AIDS Awareness Day reminds us that worldwide, our mothers, daughters, sisters, aunts, cousins and friends are struggling w
National Institutes of Health, National Institute of Allergy and Infectious Diseases - Monday, March 5, 2007
CONTACT: NIAID News Office, 301-402-1663,
The commemoration of the second annual National Women and Girls HIV/AIDS Awareness Day reminds us that worldwide, our mothers, daughters, sisters, aunts, cousins and friends are struggling with HIV/AIDS in growing numbers, and becoming infected with HIV at alarming rates. The imperative to bolster our collective commit
U.S. Department of Health and Human Services; National Institutes of Health, National Institute of Allergy and Infectious Diseases - Wednesday, February 14, 2007
CONTACT: Anne Oplinger, 301-402-1663,
In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when
U.S. Department of Health and Human Services; National Institutes of Health, National Institute of Allergy and Infectious Diseases - For Immediate Release: Thursday, February 8, 2007
CONTACT: NIAID News Office, Anne Oplinger, 301-402-1663, e-mail: aoplinger@niaid.nih.gov
A large-scale clinical trial of a candidate HIV vaccine -- which previously showed promise in smaller studies in the United States and elsewhere -- has now opened in South Africa . The study plans to enroll up to 3,000 HIV-negative men and women, making it the largest African HIV vaccine trial to date. Conducted jo
On February 7th, we commemorate the seventh annual National Black HIV/AIDS Awareness and Information Day. This day of recognition reminds us of the devastation that HIV/AIDS continues to inflict on African American communities. Although African Americans account for only 13 percent of the U.S. population, in 2005 they
This information is designed to support, not replace, the relationship that exists between you and your doctor.